Anzeige
Mehr »
Donnerstag, 26.02.2026 - Börsentäglich über 12.000 News
Während Washington Kupfer strategisch erklärt, schärft diese Aktie ihr Modell
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Insider Monkey

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
Di11 Newly-Listed NASDAQ Stocks to Buy Now
Di11 High Growth Financial Stocks to Buy Now
DiElbit Systems (ESLT) Secures $277 Million in Contracts from Unnamed International Customer
DiHEICO Corporation's (HEI) Wencor Group Acquires EthosEnergy Accessories and Components
DiL3Harris Technologies (LHX) Lands its Biggest Ever Full-Rate Production Contract For Submarine Communication Systems
DiLockheed Martin Corporation (LMT) Secures Foreign Military Sale Contract Through Wright-Patterson Air Force Base
DiThe Boeing Company's (BA) 777-9 Flight Training Simulators Receives Qualification Certification
DiRTX Corporation (RTX) Gets Complete Approval for StormBreaker Smart Weapon
DiUnited Airlines selects GE Aerospace (GE)'s GEnx Engines for Boeing 787
DiHere's Artisan Mid Cap Fund's Updates on iRhythm (IRTC)
DiIn-line Results and Stronger Than Expected Outlook Lifted MACOM Technology Solutions Holdings, Inc. (MTSI) Higher
DiArtisan Mid Cap Fund Maintains Its Confidence in Argenx's (ARGX) VYVGART
DiDo You Believe in Coherent's (COHR) Longer-Term Growth Opportunities?
DiInsmed Incorporated (INSM) Gained from Its Lead Product ARIKAYCE
DiArtisan Mid Cap Fund Bets on MongoDB's (MDB) Atlas cloud platform
DiDo You Have Conviction in the Durability of ServiceTitan's (TTAN) Profit Cycle
Di11 Most Undervalued Penny Stocks to Buy Right Now
DiMicrosoft (MSFT) Needs a Refresh, Says Jim Cramer
DiI Would Raise CrowdStrike (CRWD)'s Numbers, Says Jim Cramer
Di12 Cheap NASDAQ Stocks To Buy in 2026
DiEquinor (EQNR), Eneco Enter Five-Year Gas Supply Agreement for Dutch Market
DiFDA Accepts Regeneron (REGN) BLA for Garetosmab Under Priority Review
DiGSK (GSK) Announces 75.6% Vaccine Effectiveness for Arexvy in Real-World RSV Study
DiFDA Accepts Bristol Myers Squibb (BMY) NDA for Iberdomide With Priority Review
Di13 Best Strong Buy Dividend Stocks to Invest In